Literature DB >> 28420067

Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience.

J Naranjo-Escobar1,2, E Manzi3, J G Posada4, L Mesa4, G J Echeverri5, C Duran4, J Schweneiberg4, L A Caicedo5, J I Villegas5, G J Tobón2,6.   

Abstract

Background Lupus nephritis (LN) is one of the most frequent complications of SLE and occurs in up to 50% of cases depending on the studied population. Of these, approximately 20% progress to end-stage renal disease (ESRD), with the treatment of choice being a kidney transplant. Objective The objective of this study was to describe the clinical outcome of patients transplanted due to LN, compared with patients transplanted for other causes, in a Latin American population from the Fundación Valle del Lili in Cali, Colombia. Methods Observational, retrospective case study with controls matched by age, sex and type of donor in a single center between 1996 and 2014. Results Sixty-five kidney transplants were performed in patients with LN and ESRD. The survival of patients with LN was 98% at 1, 10 and 15 years ( p = .99). For controls by age and sex, survival was also 98% at 15 years post-transplant, and for controls by donor, the survival rate was 100% at 5 years and 98% at 15 years. Graft survival in patients with LN to 1, 5 and 15 years was 92%, 83% and 71%, respectively; for controls by age and sex, it was 90%, 84% and 64%, respectively, and for the controls by donor, it was 89%, 86% and 79%, respectively ( p = .7718). There were no statistically significant differences found in the cumulative incidence of acute graft rejection in the first year, but it was found that acute rejection is a factor that relates to the loss of function of the renal graft ( p = .032). Of the patients transplanted for LN, two (3.1%) experienced a recurrence of the disease. One patient died after a diagnosis of recurrence of LN due to an infection. Conclusions Kidney transplantation is a good option for patients with ESRD due to LN. In this Hispanic population, the survival of patients, graft survival, and cumulative incidence of graft rejection are not different from those of other transplanted patients. In addition, recurrence of LN was rare, showing the benefits of renal transplantation in LN patients with ESRD.

Entities:  

Keywords:  Systemic lupus erythematosus; end-stage renal disease; kidney transplant; lupus nephritis

Mesh:

Year:  2017        PMID: 28420067     DOI: 10.1177/0961203317696591

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  Methodological considerations in comparing access to Pre-emptive renal transplantation between SLE and other ESRD causes in the USRDS.

Authors:  Anna Broder; Wenzhu B Mowrey; Ladan Golestaneh; Chaim Putterman; Karen H Costenbader; Mimi Kim
Journal:  Semin Arthritis Rheum       Date:  2018-06-12       Impact factor: 5.532

2.  Recurrent lupus nephritis in renal allograft triggered by pregnancy.

Authors:  Takahiro Shinzato; Toshihiro Shimizu; Daiki Iwami; Noriyoshi Fukushima; Kenichi Tabata
Journal:  CEN Case Rep       Date:  2021-11-11

3.  Early outcomes in kidney transplant recipients with systemic lupus erythematosus.

Authors:  Jorge Mario López-Morales; Lauro Quintanilla-González; Juan Carlos Ramírez-Sandoval; Andrea Hinojosa-Azaola
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

Review 4.  Relationship between TGF-β1 + 869 T/C and + 915 G/C gene polymorphism and risk of acute rejection in renal transplantation recipients.

Authors:  Hong-Yan Li; Tianbiao Zhou; Shujun Lin; Wenshan Lin
Journal:  BMC Med Genet       Date:  2019-06-25       Impact factor: 2.103

5.  Relapse and Outcome of Lupus Nephritis After Renal Transplantation in the Modern Immunosuppressive Era.

Authors:  Debendra Pattanaik; Joseph Green; Manish Talwar; Miklos Molnar
Journal:  Cureus       Date:  2022-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.